Release Date: 03/10/11 08:16 Summary: 30 June 2011 Financial Statements Price Sensitive: No Download Document 1.14MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%